4 - Augmedix, Inc. (0001769804) (Issuer)

4 - Augmedix, Inc. (0001769804) (Issuer)

4 - Augmedix, Inc. (0001769804) (Issuer)

4 - Augmedix, Inc. (0001769804) (Issuer)

4 - Augmedix, Inc. (0001769804) (Issuer)

4 - Augmedix, Inc. (0001769804) (Issuer)

4 - Augmedix, Inc. (0001769804) (Issuer)

4 - Augmedix, Inc. (0001769804) (Issuer)

4 - Augmedix, Inc. (0001769804) (Issuer)

4 - Augmedix, Inc. (0001769804) (Issuer)

4 - Augmedix, Inc. (0001769804) (Issuer)

4 - Augmedix, Inc. (0001769804) (Issuer)

15-12G - Augmedix, Inc. (0001769804) (Filer)

EFFECT - Augmedix, Inc. (0001769804) (Filer)

EFFECT - Augmedix, Inc. (0001769804) (Filer)

EFFECT - Augmedix, Inc. (0001769804) (Filer)

25-NSE - Augmedix, Inc. (0001769804) (Subject)

S-8 POS - Augmedix, Inc. (0001769804) (Filer)

S-8 POS - Augmedix, Inc. (0001769804) (Filer)

S-8 POS - Augmedix, Inc. (0001769804) (Filer)

S-8 POS - Augmedix, Inc. (0001769804) (Filer)

POS AM - Augmedix, Inc. (0001769804) (Filer)

SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Commure, a healthcare technology company, announced today that it has completed the acquisition of Augmedix. Augmedix will now operate as a wholly-owned subsidiary of Commure. The merger was previously announced on July 19, 2024, and was approved by Augmedix stockholders at Augmedix's special meeting of stockholders held on September 27, 2024. With the completion of the acquisition, Augmedix stockholders are entitled to $2.35 in cash for each share of Augmedix common stock they owned immediately prior to the closing. Augmedix's stock has ceased trading and will be delisted from the Nasdaq Stock Market. "I started Augmedix to relieve clinic

SAN FRANCISCO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today it anticipates releasing second quarter 2024 results after the market closes on Monday, August 12, 2024. On July 19, 2024, Augmedix announced that it entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems. Due to this pending acquisition, management is not hosting a quarterly conference call. About Augmedix Augmedix (NASDAQ:AUGX) empowers clinicians to connect with patients by liberating them from administrative burden through the power of ambient AI, data, and

SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended March 31, 2024. "Augmedix delivered in-line first quarter performance, with 40% revenue growth, 143% net revenue retention and 47.1% gross margins," commented Manny Krakaris, Augmedix CEO. "We are confident about our positioning within the medical documentation market, and expect to report continued growth throughout the rest of the year. It is now clear, however, that health systems are proceeding methodically while they develop a better understanding of the capabilities of AI products." "We a

SAN FRANCISCO, April 30, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today it will release first quarter 2024 results after the market closes on Monday, May 13, 2024. Following the release, management will host a conference call that same day at 1:30 p.m. PT / 4:30 p.m. ET. Live conference call: 877-407-3982 (Toll-Free) and 201-493-6780 (International)Live webcast: https://viavid.webcasts.com/starthere.jsp?ei=1666696&tp_key=f217dd82fa An archived replay will be available following the call on Augmedix's IR website at https://ir.augmedix.com/. About Augmedix Augmedix (NASDAQ:AUGX) empowers clinicians to conn

SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three and 12 months ended December 31, 2023. "The fourth quarter was a solid end to a strong year for Augmedix both operationally and financially," stated Augmedix CEO Manny Krakaris. "We delivered a 45% increase in revenue to $12.7 million, ahead of our most recent guidance, driven by a 44% increase in clinicians in service and net revenue retention of 152%. Additionally, we made steady progress toward our profitability goals by increasing gross profit by 54% to $6.2 million, a margin expansion of 300 basis poi

SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will release fourth quarter and full year 2023 results after the market closes on Monday, March 18, 2024. Following the release, management will host a conference call and audio webcast to review results and provide a brief business and outlook update that same day at 1:30 p.m. PT / 4:30 p.m. ET. Live conference call: 877-407-3982 (Toll-Free) and 201-493-6780 (International)Live webcast: https://viavid.webcasts.com/starthere.jsp?ei=1656407&tp_key=3507378dc0 An archived replay will be

SAN FRANCISCO, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced preliminary revenue results and operational metrics for the fourth quarter of 2023. "Augmedix's expected fourth quarter revenue of approximately $12.5 million puts us on pace to deliver a solid finish to a strong year," stated Augmedix CEO Manny Krakaris. "We enter 2024 with approximately $51 million in expected Annual Recurring Revenue, driven by strong adoption of Augmedix Live and Augmedix Notes by our health system customers. With Augmedix Go now generally available in the ambulat

SAN FRANCISCO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, reported today financial results for the three and nine months ended September 30, 2023. "The third quarter marked another period of strong progress for Augmedix as we continue to be a leader in the large and rapidly growing ambient medical documentation market," commented Manny Krakaris, Chief Executive Officer at Augmedix. "Growing adoption of Augmedix Live and Augmedix Notes drove 50% revenue growth and net revenue retention of 157%, while expanding gross margins by 390 basis points to 49.5%. With stron

SAN FRANCISCO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will report financial results for the third quarter ended September 30, 2023, on Monday, November 6, 2023, after the market closes. Management will host a conference call that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the conference call will be available on the "Events" section of the Company's website at: https://ir.augmedix.com/news-events. Alternatively, interested parties can dial 877-407-3982 (toll-free) or 201-493-6780 (international) to listen. The we

SAN FRANCISCO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three and six months ended June 30, 2023. "This was another strong quarter for Augmedix, as we continue to solidify our position within the burgeoning ambient medical documentation market," commented Manny Krakaris, Chief Executive Officer at Augmedix. "We set records for revenue, growing 47% year-over-year, and dollar-based net revenue retention at 148%, demonstrating that healt

SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Commure, a healthcare technology company, announced today that it has completed the acquisition of Augmedix. Augmedix will now operate as a wholly-owned subsidiary of Commure. The merger was previously announced on July 19, 2024, and was approved by Augmedix stockholders at Augmedix's special meeting of stockholders held on September 27, 2024. With the completion of the acquisition, Augmedix stockholders are entitled to $2.35 in cash for each share of Augmedix common stock they owned immediately prior to the closing. Augmedix's stock has ceased trading and will be delisted from the Nasdaq Stock Market. "I started Augmedix to relieve clinic

SAN FRANCISCO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended June 30, 2024. "We believe we are approaching the proposed combination with Commure, Inc. from a position of strength, with consistent double-digit revenue growth and improving gross margins," commented Manny Krakaris, Augmedix CEO. "Together, we believe we will be well-positioned to continue to streamline the medical documentation ecosystem with a growing base of health system customers, solid partners, and proven solutions. As part of Commure, we expect to scale our ambient documentation solu

SAN FRANCISCO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today it anticipates releasing second quarter 2024 results after the market closes on Monday, August 12, 2024. On July 19, 2024, Augmedix announced that it entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems. Due to this pending acquisition, management is not hosting a quarterly conference call. About Augmedix Augmedix (NASDAQ:AUGX) empowers clinicians to connect with patients by liberating them from administrative burden through the power of ambient AI, data, and

SAN FRANCISCO, July 19, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced that it has entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems, in an all-cash transaction that values Augmedix at approximately $139 million in equity value. Under the terms of the agreement, Augmedix stockholders will receive $2.35 per share in cash upon completion of the proposed transaction, and Augmedix will become a wholly-owned subsidiary of Commure. The purchase price represents a premium of approximately 169% over the volume weighted average price

SAN FRANCISCO, June 20, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today that Emergency Services Inc., a physician-owned emergency medicine services group in Columbus, Ohio, is introducing Augmedix Go ED to physicians in the emergency department (ED) at the second-largest healthcare system in central Ohio. Augmedix Go ED is the industry's first fully automated, generative AI (GenAI) powered medical documentation product for EDs nationwide. "Given the unique needs of the ED, it has been difficult to identify a documentation solution that effectively alleviates the administrative burden on our physicians – unt

SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today reiterated its expectations in advance of management's participation at the William Blair Annual Growth Stock Conference. Management continues to expect second quarter 2024 revenue to increase slightly sequentially from the first quarter of 2024, and second quarter 2024 GAAP gross margins to increase from the first quarter of 2024 by 50 to 100 basis points. For the full year of 2024, management continues to expect revenue of approximately $52 to $55 million. Management will present at the William Blair Annual Growth Stock Conference (Chicago) on

SAN FRANCISCO, May 29, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient artificial intelligence (AI) medical documentation and data solutions, today announced that Alex Stinard, M.D., has been named Chief Clinical AI Officer of the company. Dr. Stinard brings over two decades of extensive experience as an emergency medicine clinician. He has a background in data science with a specialization in large language models, computer vision, and natural language processing. This mix of experience makes Dr. Stinard uniquely qualified for this new position. "Welcoming Dr. Stinard to join Augmedix in this new role is an exciting step forward in implementing advanced AI technolog

SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended March 31, 2024. "Augmedix delivered in-line first quarter performance, with 40% revenue growth, 143% net revenue retention and 47.1% gross margins," commented Manny Krakaris, Augmedix CEO. "We are confident about our positioning within the medical documentation market, and expect to report continued growth throughout the rest of the year. It is now clear, however, that health systems are proceeding methodically while they develop a better understanding of the capabilities of AI products." "We a

SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will participate in the following four investor conferences in May and June 2024. RBC Capital Markets Global Healthcare Conference (New York): Management will participate in a fireside chat on May 15 at 10:30 a.m. ET, and be available for 1x1 investor meetings. The webcast link for the fireside chat can be found at https://ir.augmedix.com/.Benchmark Healthcare House Call Conference (Virtual): Management will be available for 1x1 investor meetings on May 21.B. Riley Annual Institutional Investor Conference (B

SAN FRANCISCO, April 30, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today it will release first quarter 2024 results after the market closes on Monday, May 13, 2024. Following the release, management will host a conference call that same day at 1:30 p.m. PT / 4:30 p.m. ET. Live conference call: 877-407-3982 (Toll-Free) and 201-493-6780 (International)Live webcast: https://viavid.webcasts.com/starthere.jsp?ei=1666696&tp_key=f217dd82fa An archived replay will be available following the call on Augmedix's IR website at https://ir.augmedix.com/. About Augmedix Augmedix (NASDAQ:AUGX) empowers clinicians to conn

SC 13D/A - Augmedix, Inc. (0001769804) (Subject)

SC 13G - Augmedix, Inc. (0001769804) (Subject)

SC 13D/A - Augmedix, Inc. (0001769804) (Subject)

SC 13G/A - Augmedix, Inc. (0001769804) (Subject)

SC 13D/A - Augmedix, Inc. (0001769804) (Subject)

SC 13G - Augmedix, Inc. (0001769804) (Subject)

SC 13D/A - Augmedix, Inc. (0001769804) (Subject)

SC 13D/A - Augmedix, Inc. (0001769804) (Subject)

SC 13D/A - Augmedix, Inc. (0001769804) (Subject)

SC 13D/A - Augmedix, Inc. (0001769804) (Subject)

Lake Street analyst Brooks O'Neil downgrades Augmedix (NASDAQ:AUGX) from Buy to Hold.

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Friday. The Dow traded down 0.91% to 40,293.66 while the NASDAQ fell 0.70% to 17,746.27. The S&P 500 also fell, dropping, 0.61% to 5,510.84. Check This Out: Wall Street’s Most Accurate Analysts Weigh In On 3 Real Estate Stocks Delivering High-Dividend Yields Leading and Lagging SectorsHeath care shares jumped by 0.5% on Thursday. In trading on Thursday, information technology shares fell by 1%. Top Headline Netflix Inc. (NASDAQ:NFLX) posted better-than-expected earnings and sales results for its second quarter, after the closing bell on Thursday. The company ende

Shares of Selective Insurance Group, Inc. (NASDAQ:SIGI) fell sharply during Friday's session following weak quarterly results. Selective Insurance reported quarterly losses of $1.10 per share which missed the analyst consensus estimate of $1.49 per share. The company reported quarterly sales of $1.196 billion which missed the analyst consensus estimate of $1.204 billion, according to data from Benzinga Pro. Selective Insurance Group shares dipped 14.8% to $85.40 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers Augmedix, Inc. (NASDAQ:AUGX) shares jumped 148.8% to $2.28 after the company announced it will be acquired by Commure. 60 Degrees Pha

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 300 points on Friday. The Dow traded down 0.78% to 40,347.51 while the NASDAQ fell 0.29% to 17,819.43. The S&P 500 also fell, dropping, 0.29% to 5,528.67. Check This Out: Wall Street’s Most Accurate Analysts Weigh In On 3 Real Estate Stocks Delivering High-Dividend Yields Leading and Lagging SectorsCommunication services shares jumped by 0.7% on Thursday. In trading on Thursday, materials shares fell by 1%. Top Headline Schlumberger N.V. (NYSE:SLB) reported better-than-expected second-quarter results. The company said revenue increased 13% year-over-year to $9.139 billion, beating

Augmedix Inc. (NASDAQ:AUGX) will be acquired by Commure, Inc., in an all-cash transaction valued at approximately $139 million in equity. Under the agreement, Augmedix stockholders will receive $2.35 per share in cash upon completion of the proposed transaction, and Augmedix will become a wholly-owned subsidiary of Commure. Augmedix delivers AI medical documentation products to healthcare systems, physician practices, hospitals, and telemedicine practitioners. Commure offers a suite of automated and AI-enabled hardware, software, and services for the healthcare sector. The purchase price represents a premium of approximately 169% over the volume-weighted average price (VWAP) of A

U.S. stocks traded mixed this morning, with the Dow Jones index falling more than 100 points on Friday. Following the market opening Friday, the Dow traded down 0.32% to 40,532.98 while the NASDAQ rose 0.14% to 17,895.95. The S&P 500 also rose, gaining, 0.17% to 5,553.92. Check This Out: Wall Street’s Most Accurate Analysts Weigh In On 3 Real Estate Stocks Delivering High-Dividend Yields Leading and Lagging SectorsCommunication services shares jumped by 1% on Thursday. In trading on Thursday, energy shares fell by 0.6%. Top Headline American Express Co (NYSE:AXP) reported better-than-expected earnings for its second quarter on Friday. The company's second-quarter revenue